# FDA Inspection 1141470 - CellTrans Inc. - May 06, 2021

Source: https://www.keypedia.com/records/fda_inspections/celltrans-inc/cc0e5dd2-d5e7-4da4-9d77-bef44455e947
Source feed: FDA_Inspections

> FDA Inspection 1141470 for CellTrans Inc. on May 06, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1141470
- Company Name: CellTrans Inc.
- Inspection Date: 2021-05-06
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1228629 - 2024-01-16](https://www.keypedia.com/records/fda_inspections/celltrans-inc/5fb3768c-09d8-4d9b-af47-816d0af963cc)
- [FDA Inspection 1141470 - 2021-05-06](https://www.keypedia.com/records/fda_inspections/celltrans-inc/cb07f656-c485-497e-9bf4-b0a6ea09020a)

Company: https://www.keypedia.com/companies/celltrans-inc/f107fb49-e519-4286-880e-2374e9ffa149

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d